Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: Insight into molecular interaction

Journal of Molecular Recognition

Volumn 23, Issue 3, 2010, Pages 283-300

  Wichapong, Kanin ^a,b   Pianwanit, Somsak ^a   Sippl, Wolfgang ^b   Kokpol, Sirirat ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Dengue NS2B NS3 protease; GRID; GROMACS; Molecular dynamics simulation; West Nile NS2B NS3 protease

Indexed keywords

NS3 PROTEASE, DENGUE VIRUS; PROTEINASE INHIBITOR; SERINE PROTEINASE; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; DENGUE VIRUS; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; MOLECULAR DYNAMICS; MOLECULAR GENETICS; PATHOGENICITY; PROTEIN TERTIARY STRUCTURE; SEQUENCE ALIGNMENT; WEST NILE FLAVIVIRUS;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; DENGUE VIRUS; HUMANS; MODELS, MOLECULAR; MOLECULAR DYNAMICS SIMULATION; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; PROTEASE INHIBITORS; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT; SERINE ENDOPEPTIDASES; VIRAL NONSTRUCTURAL PROTEINS; WEST NILE VIRUS;

DENGUE VIRUS; WEST NILE VIRUS;

EID: 77950675654     PISSN: 09523499     EISSN: 10991352     Source Type: Journal    
DOI: 10.1002/jmr.977     Document Type: Article

References (56)

1. Aleshin AE, Shiryaev SA, Strongin AY, Liddington RC. 2007. Structural evidence for regulation and specificity of flaviviral protease and evolution of the Flaviviridae fold. Protein Sci. 16(5): 795-806.
2. Beasley DW. 2005. Recent advances in the molecular biology of West Nile Virus. Curr. Mol. Med. 5(8): 835-850.
3. Berendsen HJC, Postma JPM, van Gunsteren WF, Hermans J. 1981. Interaction models for water in relation to protein hydration. In Intermolecular Forces, Pollman B (ed.), D. Reidel Publishing Company: Dordrecht; 331-342.
4. Berendsen HJC, Postma JPM, van Gunsteren WF, Dinola A, Haak JR. 1984. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81(8): 3684-3690.
5. Billoir F, de Chesse R, Tolou H, de Micco P, Gould EA, de Lamballerie X. 2000. Phylogeny of the genus Flavivirus using complete coding sequences of arthropod-borne viruses and viruses with no known vector. J. Gen. Virol. 81(3): 781-790.
6. Brinkworth RI, Fairlie DP, Leung D, Young PR. 1999. Homology model of the dengue 2 virus NS3 protease: putative interactions with both substrate and NS2B cofactor. J. Gen. Virol. 80: 1167-1177.
7. Butkiewicz N, Yao N, Zhong W, Wright-Minogue J, Ingravallo P, Zhang R, Durkin J, Standring DN, Baroudy BM, Sangar DV, Lemon SM, Lau JY, Hong Z. 2000. Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3. J. Virol. 74(9): 4291-4301.
8. Center for Disease Control and Prevention (CDC). 2006. Division of Vector-Borne Infectious Disease West Nile Virus, Center for Disease Control and Prevention website, http:///www.cdc.gov/ncidod/dvbid/westnile/index.htm.
9. Chambers TJ, Weir RC, Grakoui A, McCourt DW, Bazan JF, Fletterick RJ, Rice CM. 1990a. Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein. Proc. Natl. Acad. Sci. U.S.A. 87(22): 8898-8902.
10. Chambers TJ, Hahn CS, Galler R, Rice CM. 1990b. Flavivirus genome organization, expression, and replication. Annu. Rev. Microbiol. 44: 649-688.
11. Chappell KJ, Nall TA, Stoermer MJ, Fang NX, Tyndall JD, Fairlie DP, Young PR. 2005. Site-directed mutagenesis and kinetic studies of the West Nile Virus NS3 protease identify key enzyme-substrate interactions. J. Biol. Chem. 280(4): 2896-2903.
12. Chappell KJ, Stoermer MJ, Fairlie DP, Young PR. 2006. Insights to substrate binding and processing by West Nile Virus NS3 protease through combined modeling, protease mutagenesis, and kinetic studies. J. Biol. Chem. 281(50): 38448-38458.
13. Chappell KJ, Stoermer MJ, Fairlie DP, Young PR. 2008. Mutagenesis of the West Nile Virus NS2B cofactor domain reveals two regions essential for protease activity. J. Gen. Virol. 89: 1010-1014.
14. Clum S, Ebner KE, Padmanabhan R. 1997. Cotranslational membrane insertion of the serine proteinase precursor NS2B-NS3(Pro) of dengue type 2 is required for efficient in vitro processing and is mediated through the hydrophobic regions of NS2B. J. Biol. Chem. 272(49): 30715-30723.
15. Erbel P, Schiering N, D'Arcy A, Renatus M, Kroemer M, Lim SP, Yin Z, Keller TH, Vasudevan SG, Hommel U. 2006. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile Virus. Nat. Struct. Mol. Biol. 13(4): 372-373.
16. Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG. 1995. A smoothparticlemeshEwaldmethod. J. Chem. Phys.103(19):8577-8593.
17. Falgout B, Pethel M, Zhange YM, Lai CJ. 1991. Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins. J. Virol. 65(5): 2467-2475.
18. Falgout B, Miller RH, Lai CJ. 1993. Deletion analysis of dengue virus type 4 nonstructural protein NS2B: identification of a domain required for NS2B-NS3 protease activity. J. Virol. 67(4): 2034-2042.
19. Ganesh VK, Muller N, Judge K, Luan CH, Padmanabhan R, Murthy KH. 2005. Identification and characterization of nonsubstrate based inhibitors of the essential dengue and West Nile Virus proteases. Bioorg. Med. Chem. 13(1): 257-264.
20. Goodford PJ. 1985. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J. Med. Chem. 28(7): 849-857.
21. GRID22a. 2004. Moldiscovery Ltd. 215 Marsh Road, HA5 5NE Pinner, Middlesex, UK, 2004 Pinner, Middlesex, UK (http://www.moldiscovery.com).
22. Gubler DJ. 1998. Dengue and dengue hemorrhagic fever. Clin. Microbiol. Rev. 11(3): 480-496.
23. Gubler DJ, Clark GG. 1995. Dengue/dengue hemorrhagic fever: the emergence of a global health problem. Emerg. Infect. Dis. 1(2): 55-57.
24. Hayes CG. 2001. West Nile Virus: Uganda, 1937, to New York City, 1999. Ann. N.Y. Acad. Sci. 951: 25-37.
25. Henikoff S, Henikoff JG. 1992. Amino acid substitution matrices from protein blocks. Proc. Natl. Acad. Sci. U.S.A. 89(22): 10915-10919.
26. Humphrey W, Dalke A, Schulten K. 1996. VMD: visual molecular dynamics. J. Mol. Graph 14(1): 33-38. 27-28.
27. Irie K, Mohan PM, Sasaguri Y, Putnak R, Padmanabhan R. 1989. Sequence analysis of cloned dengue virus type 2 genome (New Guinea-C strain). Gene 75(2): 197-211.
28. Keelapang P, Sriburi R, Supasa S, Panyadee N, Songjaeng A, Jairungsri A, Puttikhunt C, Kasinrerk W, Malasit P, Sittisombut N. 2004. Alterations of pr-M cleavage and virus export in pr-M junction chimeric dengue viruses. J. Virol. 78(5): 2367-2381.
29. Knox JE, Ma NL, Yin Z, Patel SJ, Wang WL, Chan WL, Ranga Rao KR, Wang G, Ngew X, Patel V, Beer D, Lim SP, Vasudevan SG, Keller TH. 2006. Peptide inhibitors of West Nile NS3 protease: SAR study of tetrapeptide aldehyde inhibitors. J. Med. Chem. 49(22): 6585-6590.
30. Laskowski RA, MacArthur MW, Moss DS, Thornton JM. 1993. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Cryst. 26: 283-291.
31. Leung D, Schroder K, White H, Fang NX, Stoermer MJ, Abbenante G, Martin JL, Young PR, Fairlie DP. 2001. Activity of recombinant Dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors. J. Biol. Chem. 276(49): 45762-45771.
32. Li J, Lim SP, Beer D, Patel V, Wen D, Tumanut C, Tully DC, Williams JA, Jiricek J, Priestle JP, Harris JL, Vasudevan SG. 2005. Functional profiling of recombinant NS3 proteases from all four serotypes of Dengue virus using tetrapeptide and octapeptide substrate libraries. J. Biol. Chem. 280(31): 28766-28774.
33. Lin C, Amberg SM, Chambers TJ, Rice RM. 1993. Cleavage at a novel site in the NS4A region by the yellow fever virus NS2B-3 proteinase is a prerequisite for processing at the downstream 4A/4B signalase site. J. Virol. 67: 2327-2335.
34. Lindahl E, Hess B, van der Spoel D. 2001. Gromacs 3.0: a package for molecular simulationand trajectory analysis. J. Mol. Model.7(8): 306-317.
35. Lobigs M. 1993. Flavivirus premembrane protein cleavage and spike heterodimer secretion require the function of the viral proteinase NS3. Proc. Natl. Acad. Sci. U.S.A. 90(13): 6218-6222.
36. Melino S, Fucito S, Campagna A, Wrubl F, Gamarnik A, Cicero DO, Paci M. 2006. The active essential CFNS3d protein complex. FEBS J 273(16): 3650-3662.
37. MOE. 2006. 2006.08. Chemical Computing Group Inc., 1010 Sherbrooke St. W, Suite 910, Montreal, Quebec, Canada H3A 2R7, (http://www.chemcomp.com).
38. Mukhopadhyay S, Kuhn RJ, Rossmann MG. 2005. A structural perspective of the flavivirus life cycle. Nat. Rev. Microbiol. 3(1): 13-22.
39. Murthy HM, Clum S, Padmanabhan R. 1999. Dengue Virus NS3 serine protease. Crystal structure and insights into interaction of the active site with substrates by molecular modeling and structural analysis of mutational effects. J. Biol. Chem. 274(9): 5573-5580.
40. Murthy HM, Judge K, DeLucas L, Padmanabhan R. 2000. Crystal structure of Dengue virus NS3 protease in complex with a Bowman-Birk inhibitor: implications for flaviviral polyprotein processing and drug design. J. Biol. Chem. 301(4): 759-767.
41. Nall TA, Chappell KJ, Stoermer MJ, Fang NX, Tyndall JD, Young PR, Fairlie DP. 2004. Enzymatic characterization and homology model of a catalytically active recombinant West Nile Virus NS3 protease. J. Biol. Chem. 279(47): 48535-48542.
42. Needleman SB, Wunsch CD. 1970. A general method applicable to the search for similarities in the amino acid sequence of two proteins. J. Mol. Biol. 48(3): 443-453.
43. Niyomrattanakit P, Winoyanuwattikun P, Chanprapaph S, Angsuthanasombat C, Panyim S, Katzenmeier G. 2004. Identification of residues in the Dengue Virus type 2 NS2B cofactor that are critical for NS3 protease activation. J. Virol. 78(21): 13708-13716.
44. Preugschat F, Strauss JH. 1991. Processing of nonstructural proteins NS4A and NS4B of dengue 2 virus in vitro and in vivo. Virology 185(2): 689-697.
45. Radichev I, Shiryaev SA, Aleshin AE, Ratnikov BI, Smith JW, Liddington RC, Strongin AY. 2008. Structure-based mutagenesis identifies important novel determinants of the NS2B cofactor of the West Nile Virus two-component NS2B-NS3 proteinase. J. Gen. Virol. 89: 636-641.
46. Samuel CE. 2002. Host genetic variability and West Nile Virus susceptibility. Proc. Natl. Acad. Sci. U.S.A. 99(18): 11555-11557.
47. Shiryaev SA, Aleshin AE, Ratnikov BI, Smith JW, Liddington RC, Strongin AY. 2007. Expression and purification of a two-component flaviviral ptoteinase resistant to autocleavage at the NS2B-NS3 junction region. Protein Expr. Purif. 52(2): 334-339.
48. Thomas G. 2002. Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat. Rev. Mol. Cell. Biol. 3(10): 753-766.
49. van der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJ. 2005. GROMACS: fast, flexible and free. J. Comput. Chem. 26(16): 1701-1718.
50. van Gunsteren WF, Billeter SR, Eising AA, Hunenberger PH, Kruger P, Mark AE, Scott WRP, Tironi IG. 1996. Biomolecular Simulation: The GROMOS96 Manual and User Guide. Hochschulverlag AG an der ETH: Zurich, Switzerland.
51. Wheeler DL, Barrett T, Benson DA, Bryant SH, Canese K, Chetvernin V, Church DM, Dicuccio M, Edgar R, Federhen S, Feolo M, Geer LY, Helmberg W, Kapustin Y, Khovayko O, Landsman D, Lipman DJ, Madden TL, Maglott DR, Miller V, Ostell J, Pruitt KD, Schuler GD, Shumway M, Sequeira E, Sherry ST, Sirotkin K, Souvorov A, Starchenko G, Tatusov RL, Tatusova TA, Wagner L, Yaschenko E. 2008. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 36: D13-D21.
52. Wilmouth RC, Edman K, Neutze R, Wright PA, Clifton IJ, Schneider TR, Schofield CJ, Hajdu J. 2001. X-ray snapshots of serine protease catalysis reveal a tetrahedral intermediate. Nat. Struct. Biol. 8(8): 684-689.
53. Yamshchikov VF, Compans RW. 1994. Processing of the intracellular form of the West Nile Virus capsid protein by the NS2B-NS3 protease: an in vitro study. J. Virol. 68(9): 5765-5771.
54. Yin Z, Patel SJ, Wang WL, Chan WL, Ranga Rao KR, Wang G, Ngew X, Patel V, Beer D, Knox JE, Ma NL, Ehrhardt C, Lim SP, Vasudevan SG, Keller TH. 2006. Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors. Bioorg. Med. Chem. Lett. 16(1): 40-43.
55. Yusof R, Clum S, Wetzel M, Murthy HM, Padmanabhan R. 2000. Purified NS2B/NS3 serine protease of Dengue virus type 2 exhibits cofactor NS2B dependence for cleavage for substrates with dibasic amino acids in vitro. J. Biol. Chem. 275(14): 9963-9969.
56. Zuo Z, Liew OW, Chen G, Chong PC, Lee SH, Chen K, Jiang H, Puah CM, Zhu W. 2009. Mechanism of NS2B-mediated activation of NS3pro in dengue virus: molecular dynamics simulations and bioassays. J. Virol. 83(2): 1060-1070.